Mirum Pharmaceuticals (MIRM) PT Raised to $125 at TD Cowen

March 27, 2026 6:24 AM

TD Cowen analyst Joseph Thome raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $125.00 (from $117.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found